EGF receptor tyrosine kinase inhibition attenuates the development of PKD in Han:SPRD rats
- 1 November 2003
- journal article
- Published by Elsevier in Kidney International
- Vol. 64 (5) , 1573-1579
- https://doi.org/10.1046/j.1523-1755.2003.00256.x
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Treatment prospects for autosomal-dominant polycystic kidney diseaseKidney International, 2001
- Targeted expression of a dominant-negative EGF-R in the kidney reduces tubulo-interstitial lesions after renal injuryJournal of Clinical Investigation, 2000
- Treatment of polycystic kidney disease with a novel tyrosine kinase inhibitorKidney International, 2000
- Tyrosine kinase activity of the EGF receptor in murine metanephric organ cultureKidney International, 1995
- Epidermal growth factor receptor expression is abnormal in murine polycystic kidneyKidney International, 1995
- Hereditary Error in Epidermal Growth Factor Prohormone Metabolism in a Rat Model of Autosomal Dominant Polycystic Kidney DiseaseBiochemical and Biophysical Research Communications, 1993
- Autosomal-dominant polycystic kidney disease in the ratKidney International, 1993
- Defective epidermal growth factor gene expression in mice with polycystic kidney diseaseDevelopmental Biology, 1990
- Epidermal growth factor binding, stimulation of phosphorylation, and inhibition of gluconeogenesis in rat proximal tubuleJournal of Cellular Physiology, 1989
- Mouse prepro-epidermal growth factor synthesis by the kidney and other tissuesNature, 1985